In a significant stride toward enhancing care for patients with chronic kidney disease (CKD) and end-stage kidney disease (ESKD), Humana Inc. has expanded its value-based care agreement with Interwell Health to now include Florida. This collaboration aims to provide Humana Medicare Advantage members with broader access to Interwell’s specialized services, focusing on the benefits of coordinated, patient-centered care. At the core of this initiative is the objective of improving patient health outcomes by utilizing a comprehensive approach to care, guided by an extensive network of nephrologists and renal care coordinators.
A key feature of this expanded agreement is enabling eligible members to access Interwell’s extensive network, which includes 2,000 nephrologists, renal care coordinators, and a multidisciplinary in-home virtual support team. This network is designed to offer specialized and ongoing support tailored to the needs of patients suffering from CKD and ESKD. By prioritizing value-based care, Humana aims to ensure that healthcare efforts are not merely reactive but are designed to prevent complications and improve the quality of life for patients. With a proven track record, Humana reports a 5% reduction in unnecessary hospital admissions in 2023, demonstrating the efficacy of such partnerships.
The Success of Value-Based Care
One compelling example of the success achieved through this approach is the story of Mary Johnson, a patient who received a preemptive kidney transplant with the support of Interwell’s care team. Patients like Mary benefit significantly from the customized care plans and robust support systems that address their specific medical needs. This personalized approach not only addresses existing health challenges but also proactively mitigates potential future complications. Furthermore, by expanding these services across multiple states—14 states for CKD and 39 for ESKD—Humana and Interwell Health highlight the growing emphasis on and availability of specialized care.
Dr. George Hart, Chief Medical Officer of Interwell Health, underscores the positive impacts seen when patients have access to a dedicated care team. “Patients thrive when provided with coordinated care that attends to their holistic needs, from regular nephrology consultations to timely interventions and support services,” said Dr. Hart. This sentiment encapsulates the overarching trend of value-based care, which aims to shift the focus from volume to value, ensuring that every aspect of patient care is meticulously managed to produce the best possible outcomes.
Expanding Specialized Care
In a major step forward for improving care for chronic kidney disease (CKD) and end-stage kidney disease (ESKD) patients, Humana Inc. is expanding its value-based care deal with Interwell Health to include Florida. This partnership aims to give Humana Medicare Advantage members better access to Interwell’s specialized services, emphasizing the advantages of coordinated, patient-centered care. The goal is to enhance patient health outcomes through a well-rounded approach led by a vast network of nephrologists and renal care coordinators.
A standout feature of this extended agreement is that it allows eligible members to tap into Interwell’s vast network, which includes 2,000 nephrologists, renal care coordinators, and a home-based virtual support team. This network is specifically designed to offer tailored, ongoing support to patients dealing with CKD and ESKD. By focusing on value-based care, Humana aims to shift healthcare efforts from being merely reactive to being preventive, thereby improving the quality of life for patients. Humana has shown a 5% reduction in unnecessary hospital admissions in 2023, highlighting the success of such collaborations.
